February 2008
Worldwide Biotech;Feb2008, Vol. 20 Issue 2, p8
Trade Publication
The article presents information on drug maker Abiomed Inc. The company is based in Danvers, Massachusetts with European headquarters in Aachen, Germany. Abiomed is the leading provider of medical devices that provide circulatory support to acute heart failure patients across the continuum of care in heart recovery. Its products are designed to enable the heart to rest, heal and recover by improving blood flow and performing the pumping of the heart.


Related Articles

  • Teva constructs R&D facility.  // Drug Store News;6/22/98, Vol. 20 Issue 9, pCP8 

    Reports on the remodeling of the Pennsylvania-based headquarters of Teva Pharmaceuticals. Size of research development and office facility being constructed.

  • BASF Restructures Pharmaceuticals; Seeks Agchems Acquisition. Alperowicz, Natasha // Chemical Week;1/26/2000, Vol. 162 Issue 4, p22 

    Looks at the plans of BASF to combine its global pharmaceuticals operations into one legal entity with a head office in London, England. Who will head the business; Rank of the company in the global pharmaceutical industry; Amount of sales in 1999; When will the company launch a rheumatoid...

  • Road Building. Mariani, Michele // Governing;Mar2003, Vol. 16 Issue 6, p58 

    Deals with the preparations made by the city of Wilmington in Delaware for the relocation of merging pharmaceutical companies Astra and Zeneca to the city. Challenges to be faced by Wilmington in accommodating the pharmaceutical company; Changes that have to be made in the roadways of the city.

  • Kendle expands into Sweden.  // European Pharmaceutical Executive;Feb/Mar2007, p13 

    The article reports on Kendle's establishment of an office in Uppsala, Sweden. It discusses the expansion of the company's access to patients across the Scandinavian region. The Uppsala location will provide Phase II-IV clinical development solutions for the company's global biopharmaceutical...

  • New Quintiles China Headquarters and Local Lab Testing Solution Announced.  // Biomedical Market Newsletter;6/18/2012, Vol. 21, p1 

    The article informs about the agreements made by the company Quintiles for the establishment of its regional headquarters for China in Shanghai and the expansion of lab testing capabilities in China. It informs that this step was taken owing to China's growing importance in the biopharmaceutical...

  • Medical Product Makers Strut Their Stuff. KEN SHREVE // Investors Business Daily;2/20/2015, pB06 

    The article provides information about medical-products group's six-month stock price performances. It highlights standout performers in the medical product group including Abiomed Inc., which makes devices designed to assist or replace the pumping function of the heart, and Cambrex Corp., a...

  • Regeneron, Abiomed Hit High. Investor's Business Daily // Investors Business Daily;8/5/2015, pA01 

    3 The biotech's Q2 EPS rose 17% to $2.89, beating.

  • Uxbridge set to fill Amgen prescription.  // EG: Estates Gazette;10/9/2004, Issue 441, p36 

    Reports on the selection of Arlingtons' Uxbridge Business Park in Great Britain as the South East office location of U.S. pharmaceutical company Amgen Inc. Background on the revised plan of Amgen for its European headquarters; Information on Arlingtons' Uxbridge Business Park.

  • Federal Equipment Company.  // Contract Pharma;2010 Directory, Vol. 11 Issue 10, p96 

    The article profiles Federal Equipment Co., a processing equipment firm located in Cleveland, Ohio. It notes that Federal Equipment offers quality equipment, outstanding services and competitive prices to the pharmaceutical industry. The company also assists organization to manage surplus...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics